Home › Calculator › XVIPF Dividend Calculator 2026
XVIPF Dividend DRIP Calculator 2026
8.16% YieldHealthcareXvivo Perfusion AB (publ) · OTC
Price: $24.50 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When XVIPF pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your XVIPF snowball 📈
$10,000 in XVIPF → $11.10M in 10 years · $73.72/month
About Xvivo Perfusion AB (publ) (XVIPF) — Dividend Analysis 2026
Xvivo Perfusion AB (publ) is a medical technology company dedicated to advancing transplantation medicine. The firm specializes in pioneering solutions for the preservation and perfusion of organs, tissues, and cells, essential for successful transplant procedures. With a significant international presence, Xvivo Perfusion operates across diverse markets, including Sweden, the United States, wider North and South America, Europe, the Middle East, Africa, and the Asia Pacific region. Among its key product offerings is the XVIVO System (XPS), an integrated, ready-to-use cardiac bypass apparatus designed for normothermic ex vivo lung perfusion (EVLP). Complementing this, the company provides the XPS Disposable Lung Kit, comprising sterile, pre-packaged components required for EVLP, and STEEN Solution, a specialized buffered extracellular fluid used for perfusing isolated donor lungs during the EVLP process. Xvivo also offers Perfadex Plus, an extracellular, low-potassium, dextran-based electrolyte solution crucial for preservation. Other significant products include the XVIVO Silicone Tubing Set for rapid flushing of donor lungs post-procurement; the XVIVO LS and XVIVO Disposable Lung Set, devices engineered for EVLP; and the XVIVO Organ Chamber, a single-use sterile container designed for the temporary storage of isolated lungs prior to their transplantation into a recipient. Additionally, the XVIVO Lung Cannula Set, a sterile, single-use disposable product, is part of their portfolio. Established in 1998, Xvivo Perfusion AB (publ) maintains its headquarters in Gothenburg, Sweden.
Compare XVIPF with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full XVIPF DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open XVIPF position with:
🌍 XVIPF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold XVIPF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 8.16% | 5.36% | $816 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 6.94% | 4.14% | $694 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 6.53% | 3.73% | $653 / yr |
| 🇬🇧 UK ISA | 0% | 8.16% | 5.36% | $816 / yr |
| 🇬🇧 UK Taxable | 8.75% | 7.45% | 4.65% | $745 / yr |
| 🇨🇦 TFSA | 0% | 8.16% | 5.36% | $816 / yr |
| 🇨🇦 CA Taxable | 25% | 6.12% | 3.32% | $612 / yr |
| 🇦🇺 Super (pension) | 15% | 6.94% | 4.14% | $694 / yr |
| 🇦🇺 AU Taxable | 30% | 5.71% | 2.91% | $571 / yr |
| 🇩🇪 DE Taxable | 26.375% | 6.01% | 3.21% | $601 / yr |
| 🇫🇷 FR Taxable | 30% | 5.71% | 2.91% | $571 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 XVIPF Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 XVIPF Dividend Payment Schedule
XVIPF pays quarterly — 4 times per year. Next ex-div: TBD.
📊 XVIPF vs Healthcare Benchmarks
How XVIPF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for XVIPF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ XVIPF Insider Activity
No recent SEC filings reported in the last 90 days.Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the XVIPF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Xvivo Perfusion AB (publ) (XVIPF) is currently trading at $24.50, 52% below its 52-week high. The current dividend yield is 8.16% based on an annual payout of $2.00 per share.
XVIPF (Xvivo Perfusion AB (publ)) — 8.16% Dividend Yield Analysis
Xvivo Perfusion AB (publ) (XVIPF) is a healthcare stock currently trading at $24.50 with a dividend yield of 8.16%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (8.16%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.